This prenatal methylazoxymethanol acetate (MAM) rodent model disrupts development and has been implicated in some histological, neurophysiological, and behavioral deficits analogous to those observed in schizophrenia patients (Chen, Perez, & Lodge, 2014). The animals used in this experiement are second filial generation MAM (F2 MAM) rats. F2 MAM rats(experimental group) were treated during adolescence with either WIN55,212-2 or veichle. Control for MAM rats were injected with saline and either WIN55,212-2 or vehicle.
Western Blot Four 12 well gels were loaded with vHipp samples from each group at 20µL with a full range rainbow ladder loaded at 10µL. Membranes were probed for CNRIP (1:5k) and CBR1(1:5k) as well as with GAPDH (1:1k) which was used as a control. Analysis of western results was obtained using imageJ and statistics were conducted using Excel and Prism Graphpad.
Results: Analysis of western blots showed a significant difference between groups F(3,28)=3.505, p=0.0282. A Newman-Keuls post-hoc test was then conducted and showed a significant difference between the F2 saline/vehicle injected rats (m= 1.226 +/- 0.1037) and the F2 MAM WIN injected rats (m=0.8415 +/- 0.